Prevention of immunosuppressive therapy or chemotherapy-induced reactivation of hepatitis B virus infection: Joint report of the Intractable Liver Diseases Study Group of Japan and the Japanese Study Group of the Standard Antiviral Therapy for Viral Hepatitis
Hirohito Tsubouchi(Kagoshima University), Yasuhiko Sugawara(Kumamoto University), 桶谷 真, Norihiro Kokudo(National Center for Global Health and Medicine), Yasuhiro Takikawa(Iwate Medical University), 溝上 雅史, Hisataka Moriwaki(Matsunami General Hospital), Hiromi Ishibashi(Nagasaki Medical Center), 熊田 博光, 梅村 武司, 遠藤 龍人, Satoshi Mochida(Saitama Medical University), Hiroshi Yatsuhashi(Nagasaki Medical Center), 井戸 章雄, 日比 紀文, Hirofumi Uto(Yazaki (United States)), 市田 隆文, 中山 伸朗, Koji Yano(Beth Israel Deaconess Medical Center), Eiji Tanaka(Shinshu University), 與芝 眞彰, 多田 慎一郎, 木曽 真一, 藤澤 知雄, Yasuhito Tanaka(Kumamoto University), 鈴木 一幸
Cited by 70
Related Papers
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
|Hepatology|1990|1.2k
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780